力生制药 (002393)
TIANJIN LISHENG PHARMACEUTICAL CO.,LTD.
K-Line Chart
No K-line data available
Company NameTianjin Lisheng Pharmaceutical Co., Ltd.
Listing Date2010-04-23
Issue Price45RMB
Registered Capital25761.685910k RMB
Legal RepresentativeZhang Ping
Registered AddressNo. 16, Saida North 1st Road, Xiqing Economic and Technological Development Zone, Tianjin
IndustryChemical Pharmaceuticals
Main BusinessEngaged in the production and sales of chemical drug tablets, hard capsules, dropping pills, freeze-dried powder injections, water injections, active pharmaceutical ingredients (APIs), and other products.
Company ProfileTianjin Lisheng Pharmaceutical Co., Ltd. is a large enterprise in Tianjin's pharmaceutical system. It has created over 100 series of famous brand trademarks and drugs, such as the "Sanyu" brand Nanbao (Male Treasure), "Amfenicol Caffeine Aspirin Tablets" (Zhengtong Pian), the "Li" brand "Gaiweiping", and the Shoubishan Indapamide Tablets, enjoying high reputation nationwide. In recent years, the company has been repeatedly rated as one of China's Top 100 Largest Pharmaceutical Industrial Enterprises, an Advanced Enterprise in Reform Trials, an Excellent Enterprise, an Advanced Enterprise in Scientific and Technological Progress, and has been awarded honors such as the "National May 1st Labor Certificate". Its profit ranking in the pharmaceutical industry was 41st in 1994, 46th in 1999, and 33rd in 2001.
Stock Details
1. Key Indicators
- Total Shares(W): 25761.69
- Circulating A-Shares(W): 25101.68
- Earnings Per Share(RMB): 1.4400
- Net Assets Per Share(RMB): 19.2839
- Operating Revenue(W RMB): 100728.04
- Total Profit(W RMB): 43301.48
- Net Profit Attributable to Parent(W RMB): 37074.04
- Net Profit Growth Rate(%): 119.05
- Weighted Return on Equity(%): 7.6800
- Operating Cash Flow Per Share(RMB): 0.4840
- Undistributed Profit Per Share(RMB): 6.7378
- Capital Reserve Per Share(RMB): 6.2701
2. Main Business
The main business covers:
- Research, development, production and sales of pharmaceutical products
3. Company Basic Information
- Company Name: Tianjin Lisheng Pharmaceutical Company Ltd.
- Listing Date: 2010-04-23
- Industry: Pharmaceutical Manufacturing
- Address: No. 16, Saida North First Road, Xiqing Economic and Technological Development Zone, Tianjin, China
- Website: www.lishengpharma.com
- Company Profile：On July 27, 2001, the Tianjin Municipal Finance Bureau approved the equity structure plan of the aforementioned promoters with document Jin Cai Qi Yi [2001] No. 77. On August 3, 2001, the Tianjin Municipal People's Government issued document Jin Gu Pi [2001] No. 9 "Approval on the Establishment of Tianjin Lisheng Pharmaceutical Co., Ltd.", approving the establishment of the joint stock company. On August 8, 2001, the issuer registered with the Tianjin Administration for Industry and Commerce, obtained the "Business License of Enterprise Legal Person", with a registered capital of 136,454,992 yuan.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Tianjin Jinhao Pharmaceutical Co., Ltd. | General Legal Person | 13119.49 | 52.41 |
| 2 | Tianjin Xiqing Economic Development Group Co., Ltd. | General Legal Person | 182.21 | 0.73 |
5. Concept Sectors
- Biological Vaccine
- Vitamin
- Nuclear Pollution Control
- Hepatitis Concept
- Innovative Drug
- Synthetic Biology
- Margin Trading & Securities Lending
- High-Performance Stock
- Specialized, Refined, Distinctive, and Innovative SME
- Small-Cap State-Owned Enterprise
- CSI Buyback Index
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information